P-1

P-1 is a class of drugs known as GLP-1s, used for weight management and metabolic conditions.

Why it’s in the news: It is in the news due to a clinical trial showing its effectiveness in maintaining weight loss and a debate over its use as a lifestyle drug versus a medical treatment.

Latest on P-1

• We’re still figuring out the side effects of GLP-1 weight-loss drugs
• GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution
• Opinion: I studied GLP-1 use in children. The results are reassuring
• STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’
• STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more
• A 1980s PDP-11 is still running Unix – and now you can watch

Connections

1 entities linked to P-1 across the news graph.